New and old mechanisms associated with hypertension in the elderly

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Mateos Cáceres, Petra J ^a   Zamorano León, Jose J ^a   Rodríguez Sierra, Pablo ^a   MacAya, Carlos ^a   López Farré, Antonio J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIURETIC AGENT; INDAPAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRENDIPINE; NITRIC OXIDE; PERINDOPRIL; PLACEBO;

AGING; APOPTOSIS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; HUMAN; HYPERTENSION; INFLAMMATION; LIFESTYLE; MEMBRANE MICROPARTICLE; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STEM CELL; TELOMERE SHORTENING;

EID: 84868286355     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/150107     Document Type: Review

References (88)

1. Elliott W. J., welliott@rush.edu Management of hypertension in the very elderly patient. Hypertension 2004 44 6 800 804 10.1161/01.HYP.0000146909.69161. 8c (Pubitemid 39577400)
2. Ooi H. H. L., hooi@mater.ie Coleman P. L., Duggan J., O'Meara Y. M., Treatment of hypertension in the elderly. Current Opinion in Nephrology and Hypertension 1997 6 5 504 509 (Pubitemid 27397887)
3. Kannel W. B., Cobb J., Lewis B., Mancini M., Farinaro E., Framingham study: risk factors in the cohort aged 65 and older. Prevention of Cardiovascular Heart Disease in the Elderly 1991 London, UK Current Medical Literature 3 18
4. Izzo J. L., Hypertension Primer: The Essentials of High Blood Pressure 2008 4th Philadelphia, Pa, USA Lippincott Williams & Wilkins
5. Kannel W. B., Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. American Heart Journal 1999 138 3 S205 S210 2-s2.0-0032874915 (Pubitemid 29442329)
6. Amery A., Brixko P., Clement D., Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. The Lancet 1985 1 8442 1349 1354 2-s2.0-0021864792 (Pubitemid 15060905)
7. Probstfield J. L., Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 1991 265 24 3255 3264 2-s2.0-0025831464 10.1001/jama.265.24.3255
8. Staessen J., Fagaard R., Thijs L., Morbidity and mortality in the placebo controlled European Trial on Isolated Systolic Hypertension in the Elderly (SYSTEUR). The Lancet 1997 360 757 764
9. Bulpitt C. J., Fletcher A. E., Amery A., Coope J., Evans J. G., Lightowlers S., O'Malley K., Palmer A., Potter J., Sever P., Staessen J., Swift C., The hypertension in the very elderly trial (HYVET). Journal of Human Hypertension 1994 8 8 631 632 2-s2.0-0028105854 (Pubitemid 24262530)
10. Lakatta E. G., Levy D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a set up for vascular disease. Circulation 2003 107 1 139 146 2-s2.0-0037422592 10.1161/01.CIR.0000048892.83521.58 (Pubitemid 36070946)
11. Najjar S. S., Lakatta E. G., Patterson W. C., Runge M., Vascular aging: from molecular to clinical cardiology. Principles of Molecular Cardiology 2005 Totowa, NJ, USA Humana Press 517 547
12. Lakatta E. G., Central arterial aging and the epidemic of systolic hypertension and atherosclerosis. Journal of the American Society of Hypertension 2007 1 5 302 340 2-s2.0-34648828570 10.1016/j.jash.2007.05.001 (Pubitemid 47454438)
13. Virmani R., Avolio A. P., Mergner W. J., Robinowitz M., Herderick E. E., Cornhill J. F., Guo S. Y., Liu T. H., Ou D. Y., O'Rourke M., Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis: comparison between occidental and Chinese communities. American Journal of Pathology 1991 139 5 1119 1129 2-s2.0-0025992699
14. Moncada S., Palmer R. M. J., Higgs E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991 43 2 109 142 2-s2.0-0025883342
15. Moncada S., Higgs A., The L-arginine-nitric oxide pathway. New England Journal of Medicine 1993 329 27 2002 2012 2-s2.0-0027752805 10.1056/ NEJM199312303292706 (Pubitemid 24015045)
16. Csiszar A., Wang M., Lakatta E. G., Ungvari Z., Inflammation and endothelial dysfunction during aging: role of NF- κ B. Journal of Applied Physiology 2008 105 4 1333 1341 2-s2.0-55449136486 10.1152/japplphysiol.90470. 2008
17. Shi Q., Aida K., Vandeberg J. L., Xing L. W., Passage-dependent changes in baboon endothelial cellsrelevance to in vitro aging. DNA and Cell Biology 2004 23 8 502 509 2-s2.0-3943060162 10.1089/1044549041562294 (Pubitemid 39050556)
18. Chinellato A., Pandolfo L., Ragazzi E., Zambonin M. R., Froldi G., De Biasi M., Caparotta L., Fassina G., Effect of age on rabbit aortic responses to relaxant endothelium-dependent and endothelium-independent agents. Blood Vessels 1991 28 5 358 365 2-s2.0-0025870735
19. Gerhard M., Roddy M. A., Creager S. J., Creager M. A., Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996 27 4 849 853 2-s2.0-0030006173 (Pubitemid 26113830)
20. Koga T., Takata Y., Kobayashi K., Fujii K., Nagao T., Fujishima M., Age-related changes in P2-purinergic receptors on vascular smooth muscle and endothelium. Hypertension 1992 19 3 286 289 2-s2.0-0026763279
21. Moritoki H., Yoshikawa T., Hisayama T., Takeuchi S., Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide. European Journal of Pharmacology 1992 210 1 61 68 2-s2.0-0026564583 10.1016/0014-2999(92)90652-K
22. Cernadas M. R., De Miguel L. S., García-Durán M., González-Fernández F., Millás I., Montón M., Rodrigo J., Rico L., Fernández P., De Frutos T., Rodríguez-Feo J. A., Guerra J., Caramelo C., Casado S., López-Farré A., Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circulation Research 1998 83 3 279 286 2-s2.0-0032504749 (Pubitemid 28371317)
23. López-Farré A., De Miguel L. S., Caramelo C., Gómez-Macías J., García R., Mosquera J. R., De Frutos T., Millás I., Rivas F., Echezarreta G., Casado S., Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells. American Journal of Physiology 1997 272 2 H760 H768 2-s2.0-0030896420
24. Mancia G., Seravalle G., Grassi G., Systolic blood pressure: an underestimated cardiovascular risk factor. Journal of Hypertension 2002 20 supplement 5 S21 S27 2-s2.0-0036600393 10.1097/00004872-200212000-00001
25. Najjar S. S., Scuteri A., Shetty V., Wright J. G., Muller D. C., Fleg J. L., Spurgeon H. P., Ferrucci L., Lakatta E. G., Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore longitudinal study of aging. Journal of the American College of Cardiology 2008 51 14 1377 1383 2-s2.0-41149157083 10.1016/j.jacc.2007.10.065 (Pubitemid 351443076)
26. Giles T. D., Berk B. C., Black H. R., Cohn J. N., Kostis J. B., Izzo J. L., Weber M. A., Expanding the definition and classification of hypertension. Journal of Clinical Hypertension 2005 7 9 505 512 2-s2.0-33644806751
27. Adams J. D., Mukherjee S. K., Klaidman L. K., Chang M. L., Yasharel R., Apoptosis and oxidative stress in the aging brain. Annals of the New York Academy of Sciences 1996 786 135 151 2-s2.0-0029779748 (Pubitemid 26273160)
28. Usami S. I., Takumi Y., Fujita S., Shinkawa H., Hosokawa M., Cell death in the inner ear associated with aging is apoptosis? Brain Research 1997 747 1 147 150 2-s2.0-0031058394 10.1016/S0006-8993(96)01243-7 (Pubitemid 27063810)
29. Galis Z. S., Sukhova G. K., Lark M. W., Libby P., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Journal of Clinical Investigation 1994 94 6 2493 2503 2-s2.0-0028063408 (Pubitemid 24379627)
30. Warner H. R., Hodes R. J., Pocinki K., What does cell death have to do with aging? Journal of the American Geriatrics Society 1997 45 9 1140 1146 2-s2.0-0030765215 (Pubitemid 27377565)
31. Asai K., Kudej R. K., Shen Y. T., Yang G. P., Takagi G., Kudej A. B., Geng Y. J., Sato N., Nazareno J. B., Vatner D. E., Natividad F., Bishop S. P., Vatner S. F., Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1493 1499 2-s2.0-0034044004 (Pubitemid 30353879)
32. Donato A. J., Eskurza I., Silver A. E., Levy A. S., Pierce G. L., Gates P. E., Seals D. R., Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor- κ B. Circulation Research 2007 100 11 1659 1666 2-s2.0-34250216014 10.1161/01.RES.0000269183.13937.e8 (Pubitemid 46897269)
33. Hamilton C. A., Brosnan M. J., McIntyre M., Graham D., Dominiczak A. F., Superoxide excess in hypertension and aging a common cause of endothelial dysfunction. Hypertension 2001 37 2 529 534 2-s2.0-0035097953 (Pubitemid 32199023)
34. Csiszar A., Ungvari Z., Edwards J. G., Kaminski P., Wolin M. S., Koller A., Kaley G., Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circulation Research 2002 90 11 1159 1166 2-s2.0-0037076784 10.1161/01.RES.0000020401.61826.EA (Pubitemid 34786900)
35. Csiszar A., Ungvari Z., Koller A., Edwards J. G., Kaley G., Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB Journal 2003 17 9 1183 1185 2-s2.0-0038718728
36. Csiszar A., Wang M., Lakatta E. G., Ungvari Z., Inflammation and endothelial dysfunction during aging: role of NF- κ B. Journal of Applied Physiology 2008 105 4 1333 1341 2-s2.0-55449136486 10.1152/japplphysiol.90470. 2008
37. Helenius M., Hänninen M., Lehtinen S. K., Salminen A., Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. Journal of Molecular and Cellular Cardiology 1996 28 3 487 498 2-s2.0-0029670391 10.1006/jmcc.1996.0045
38. Finkel T., Holbrook N. J., Oxidants, oxidative stress and the biology of ageing. Nature 2000 408 6809 239 247 2-s2.0-0034626735 10.1038/35041687
39. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., Vlassara H., Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. Journals of Gerontology A 2007 62 4 427 433 2-s2.0-34250327529 (Pubitemid 47065712)
40. Baynes J. W., Thorpe S. R., Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999 48 1 1 9 2-s2.0-0032913309 10.2337/diabetes.48.1.1 (Pubitemid 29019345)
41. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
42. Soro-Paavonen A., Zhang W. Z., Venardos K., Coughlan M. T., Harris E., Tong D. C. K., Brasacchio D., Paavonen K., Chin-Dusting J., Cooper M. E., Kaye D., Thomas M. C., Forbes J. M., Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. Journal of Hypertension 2010 28 4 780 788 2-s2.0-77956819409 10.1097/HJH.0b013e328335043e
43. Gugliucci A., Bendayan M., Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996 39 2 149 160 2-s2.0-0030031177 10.1007/BF00403957 (Pubitemid 26031025)
44. Shanmugam N., Figarola J. L., Li Y., Swiderski P. M., Rahbar S., Natarajan R., Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 2008 57 4 879 888 2-s2.0-42449119729 10.2337/db07-1204
45. Bucala R., Tracey K. J., Cerami A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. Journal of Clinical Investigation 1991 87 2 432 438 2-s2.0-0026062122
46. Nishikawa T., Edelstein D., Du X. L., Yamagishi S. I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
47. Yan S. F., Ramasamy R., Naka Y., Schmidt A. M., Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circulation Research 2003 93 12 1159 1169 2-s2.0-0347381138 10.1161/01.RES.0000103862.26506.3D (Pubitemid 37543056)
48. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., Peppa M., Rayfield E. J., Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15596 15601 2-s2.0-0037180567 10.1073/pnas.242407999 (Pubitemid 35403978)
49. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., Vlassara H., Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. Journals of Gerontology A 2007 62 4 427 433 2-s2.0-34250327529 (Pubitemid 47065712)
50. Peppa M., Raptis S. A., Advanced glycation end products and cardiovascular disease. Current Diabetes Reviews 2008 4 2 92 100 2-s2.0-48749097985 10.2174/157339908784220732
51. Soro-Paavonen A., Zhang W. Z., Venardos K., Coughlan M. T., Harris E., Tong D. C. K., Brasacchio D., Paavonen K., Chin-Dusting J., Cooper M. E., Kaye D., Thomas M. C., Forbes J. M., Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. Journal of Hypertension 2010 28 4 780 788 2-s2.0-77956819409 10.1097/HJH.0b013e328335043e
52. Throckmorton D. C., Brogden A. P., Min B., Rasmussen H., Kashigarian M., PDGF and TGF- β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney International 1995 48 1 111 117 2-s2.0-0028980435
53. Monacelli F., Poggi A., Storace D., Durante A., Traverso N., Viviani G. L., Odetti P., Effects of valsartan therapy on protein glycoxidation. Metabolism 2006 55 12 1619 1624 2-s2.0-33751541642 10.1016/j.metabol.2006.07.024 (Pubitemid 44830135)
54. Saisho Y., Komiya N., Hirose H., Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation and glycation in Japanese type 2 diabetic subjects: blood pressure-independent effect of valsartan. Diabetes Research and Clinical Practice 2006 74 2 201 203 2-s2.0-33751071901 10.1016/j.diabres.2006.04.015 (Pubitemid 44764907)
55. Campisi J., Kim S. H., Lim C. S., Rubio M., Cellular senescence, cancer and aging: the telomere connection. Experimental Gerontology 2001 36 10 1619 1637 2-s2.0-0034774859 10.1016/S0531-5565(01)00160-7 (Pubitemid 32982869)
56. Blackburn E. H., Switching and signaling at the telomere. Cell 2001 106 6 661 673 2-s2.0-0035929353 10.1016/S0092-8674(01)00492-5 (Pubitemid 32900658)
57. Blackburn E. H., Telomere states and cell fates. Nature 2000 408 6808 53 56 2-s2.0-0034597794 10.1038/35040500
58. Pérez-Rivero G., Ruiz-Torres M. P., Rivas-Elena J. V., Jerkic M., Díez-Marques M. L., Lopez-Novoa J. M., Blasco M. A., Rodríguez- Puyol D., Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation 2006 114 4 309 317 2-s2.0-33748078758 10.1161/CIRCULATIONAHA.105.611111 (Pubitemid 44297097)
59. Demissie S., Levy D., Benjamin E. J., Cupples L. A., Gardner J. P., Herbert A., Kimura M., Larson M. G., Meigs J. B., Keaney J. F., Aviv A., Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 2006 5 4 325 330 2-s2.0-33746316181 10.1111/j.1474-9726.2006.00224.x (Pubitemid 44103248)
60. Fitzpatrick A. L., Kronmal R. A., Gardner J. P., Psaty B. M., Jenny N. S., Tracy R. P., Walston J., Kimura M., Aviv A., Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. American Journal of Epidemiology 2007 165 1 14 21 2-s2.0-33845864725 10.1093/aje/kwj346 (Pubitemid 46026204)
61. Brouilette S., Singh R. K., Thompson J. R., Goodall A. H., Samani N. J., White cell telomere length and risk of premature myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 842 846 2-s2.0-0038640076 10.1161/01.ATV.0000067426.96344.32 (Pubitemid 36566175)
62. Vasan R. S., Demissie S., Kimura M., Cupples L. A., Rifai N., White C., Wang T. J., Gardner J. P., Cao X., Benjamin E. J., Levy D., Aviv A., Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham heart study. Circulation 2008 117 9 1138 1144 2-s2.0-41149110120 10.1161/CIRCULATIONAHA.107.731794 (Pubitemid 351544068)
63. Yang Z., Huang X., Jiang H., Zhang Y., Liu H., Qin C., Eisner G. M., Jose P., Rudolph L., Ju Z., Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 2009 53 4 639 645 2-s2.0-64849091820 10.1161/HYPERTENSIONAHA.108.123752
64. Kunieda T., Minamino T., Nishi J. I., Tateno K., Oyama T., Katsuno T., Miyauchi H., Orimo M., Okada S., Takamura M., Nagai T., Kaneko S., Komuro I., Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006 114 9 953 960 2-s2.0-33748351173 10.1161/CIRCULATIONAHA.106. 626606 (Pubitemid 44337139)
65. Assmus B., Urbich C., Aicher A., Hofmann W. K., Haendeler J., Rössig L., Spyridopoulos I., Zeiher A. M., Dimmeler S., HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research 2003 92 9 1049 1055 2-s2.0-0038814315 10.1161/01.RES.0000070067.64040.7C (Pubitemid 36588505)
66. Bode-Böger S. M., Martens-Lobenhoffer J., Täger M., Schröder H., Scalera F., Aspirin reduces endothelial cell senescence. Biochemical and Biophysical Research Communications 2005 334 4 1226 1232 2-s2.0-23044438492 10.1016/j.bbrc.2005.07.014 (Pubitemid 41074705)
67. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M., Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008 198 2 347 353 2-s2.0-43949086522 10.1016/j.atherosclerosis.2007.09.040 (Pubitemid 351707385)
68. Hoetzer G. L., Van Guilder G. P., Irmiger H. M., Keith R. S., Stauffer B. L., DeSouza C. A., Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. Journal of Applied Physiology 2007 102 3 847 852 2-s2.0-33847737719 10.1152/japplphysiol.01183.2006 (Pubitemid 46377004)
69. Kushner E. J., MacEneaney O. J., Weil B. R., Greiner J. J., Stauffer B. L., DeSouza C. A., Aging is associated with a proapoptotic endothelial progenitor cell phenotype. Journal of Vascular Research 2011 48 5 408 414 10.1159/000324837
70. Van Zonneveld A. J., Rabelink T. J., Endothelial progenitor cells: biology and therapeutic potential in hypertension. Current Opinion in Nephrology and Hypertension 2006 15 2 167 172 2-s2.0-33646712619 10.1097/01.mnh. 0000214774.42103.ec
71. Giannotti G., Doerries C., Mocharla P. S., Mueller M. F., Bahlmann F. H., Horvàth T., Jiang H., Sorrentino S. A., Steenken N., Manes C., Marzilli M., Rudolph K. L., Lüscher T. F., Drexler H., Landmesser U., Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 2010 55 6 1389 1397 2-s2.0-77952953012 10.1161/HYPERTENSIONAHA.109.141614
72. Wassmann S., Werner N., Czech T., Nickenig G., Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circulation Research 2006 99 8 e74 e83 2-s2.0-33749674128 10.1161/01.RES.0000246095.90247.d4 (Pubitemid 44556373)
73. Zhou Z., Peng J., Wang C. J., Li D., Li T. T., Hu C. P., Chen X. P., Li Y. J., Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. Journal of Hypertension 2010 28 5 931 939 2-s2.0-77951299269 10.1097/HJH.0b013e3283399326
74. Wolf P., The nature and significance of platelet products in human plasma. British Journal of Haematology 1967 13 3 269 288 2-s2.0-0014082202
75. VanWijk M. J., VanBavel E., Sturk A., Nieuwland R., Microparticles in cardiovascular diseases. Cardiovascular Research 2003 59 2 277 287 2-s2.0-0142122248 10.1016/S0008-6363(03)00367-5 (Pubitemid 37272022)
76. Preston R. A., Jy W., Jimenez J. J., Mauro L. M., Horstman L. L., Valle M., Aime G., Ahn Y. S., Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003 41 2 211 217 2-s2.0-0037315391 10.1161/01.HYP.0000049760.15764.2D (Pubitemid 36204891)
77. + microparticles correlate with cardiovascular outcomes. European Heart Journal 2011 32 16 2034 2041 10.1093/eurheartj/ehq478
78. Boulanger C. M., Amabile N., Tedgui A., Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006 48 2 180 186 2-s2.0-33748147424 10.1161/01.HYP.0000231507.00962.b5 (Pubitemid 44309805)
79. Koga H., Sugiyama S., Kugiyama K., Watanabe K., Fukushima H., Tanaka T., Sakamoto T., Yoshimura M., Jinnouchi H., Ogawa H., Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. Journal of the American College of Cardiology 2005 45 10 1622 1630 2-s2.0-21044438176 10.1016/j.jacc.2005.02.047 (Pubitemid 40704497)
80. Bernal-Mizrachi L., Jy W., Jimenez J. J., Pastor J., Mauro L. M., Horstman L. L., De Marchena E., Ahn Y. S., High levels of circulating endothelial microparticles in patients with acute coronary syndromes. American Heart Journal 2003 145 6 962 970 2-s2.0-0038620493 10.1016/S0002-8703(03)00103-0 (Pubitemid 36688245)
81. Tramontano A. F., O'Leary J., Black A. D., Muniyappa R., Cutaia M. V., El-Sherif N., Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochemical and Biophysical Research Communications 2004 320 1 34 38 2-s2.0-2942682635 10.1016/j.bbrc.2004.05.127 (Pubitemid 38781781)
82. Yamazaki M., Uchiyama S., Xiong Y., Nakano T., Nakamura T., Iwata M., Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents. Thrombosis Research 2005 115 3 211 218 2-s2.0-11144344506 10.1016/j.thromres.2004.08.029 (Pubitemid 40029678)
83. Garcia B. A., Smalley D. M., Cho H., Shabanowitz J., Ley K., Hunt D. F., The platelet microparticle proteome. Journal of Proteome Research 2005 4 5 1516 1521 2-s2.0-26844452187 10.1021/pr0500760 (Pubitemid 41464776)
84. Rubin O., Crettaz D., Canellini G., Tissot J. D., Lion N., Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sanguinis 2008 95 4 289 297 2-s2.0-53849106127 10.1111/j.1423-0410. 2008.01101.x
85. Banfi C., Brioschi M., Wait R., Begum S., Gianazza E., Pirillo A., Mussoni L., Tremoli E., Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005 5 17 4443 4455 2-s2.0-28444445987 10.1002/pmic.200402017 (Pubitemid 41739922)
86. Millis R. M., Epigenetics and hypertension. Current Hypertension Reports 2011 13 1 21 28 2-s2.0-78649476514 10.1007/s11906-010-0173-8
87. Bogdarina I., Welham S., King P. J., Burns S. P., Clark A. J. L., Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research 2007 100 4 520 526 2-s2.0-33947517327 10.1161/01.RES.0000258855.60637.58 (Pubitemid 46673261)
88. Whelton P. K., PWHELTON@TULANE.EDU Appel L. J., Espeland M. A., Applegate W. B., Ettinger Jr. W. H., Kostis J. B., Kumanyika S., Lacy C. R., Johnson K. C., Folmar S., Cutler J. A., Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). Journal of the American Medical Association 1998 279 11 839 846 10.1001/jama.279.11.839 (Pubitemid 28185548)